HMGB1 and cancer: Interestingly, the temporal release of HMGB1 in the serum during cancer progression is associated with increased muscle autophagy with a consequent alteration in plasma-free amino acids and increased circulating glutamine availability to be used by cancer cells as an energy source [56].